Back
Sanofi SA Vs. Kymera Therapeutics Industry Stock Comparison
Sell
46
SNY
Sanofi SA
Last Price:
57.30
Seasonality Move:
1.61%
Buy
56
KYMR
Kymera Therapeutics
Last Price:
48.45
Seasonality Move:
25.63%
Sell
46
Sanofi SA (SNY)
is a Sell
Is Sanofi SA a Buy, Sell or Hold?
- The current Sanofi SA [SNY] share price is $57.13. The Score for SNY is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- SNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.08. The Score for KYMR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SNY Stock Price Chart
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
SNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.25 | Buy |
| Relative Strength Index (14 RSI): | 60.13 | Buy |
| Chaikin Money Flow: | 133686 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.05 - 57.71) | Buy |
| Bollinger Bands (100): | (47.95 - 54.29) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 52.52 | Buy |
| Chaikin Money Flow: | 192796 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.72 - 48.08) | Buy |
| Bollinger Bands (100): | (33 - 44.84) | Buy |
SNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.81 | Sell |
| 20-day SMA: | 56.57 | Buy |
| 50-day SMA: | 53.54 | Buy |
| 200-day SMA: | 49.7 | Buy |
| 8-day EMA: | 57.35 | Sell |
| 20-day EMA: | 56.41 | Buy |
| 50-day EMA: | 54.11 | Buy |
| 200-day EMA: | 50.91 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.85 | Buy |
| 20-day SMA: | 46.7 | Sell |
| 50-day SMA: | 43.88 | Buy |
| 200-day SMA: | 35.96 | Buy |
| 8-day EMA: | 45.93 | Buy |
| 20-day EMA: | 45.83 | Buy |
| 50-day EMA: | 43.48 | Buy |
| 200-day EMA: | 36.39 | Buy |
Sanofi SA Earnings Growth & SNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.68 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.53 per share.
Sanofi SA Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||